CoChat

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Endoscopic retrograde cholangiography (ERC) is a mainstay of therapy in patients with primary sclerosing cholangitis (PSC) and obstructive cholestasis. Patients with liver cirrhosis have an increased risk of surgical complications and are more susceptible to infections. Since PSC often progresses to cirrhosis, we aimed to assess whether ERC is associated with increased risk of complications in patients with PSC and cirrhosis. METHODS: Out of 383 patients with PSC, 208 patients received endoscopic treatment between 2009-2017. Seventy patients had cirrhosis when ERC was performed and 138 patients had no signs of cirrhosis. Overall, 663 ERC procedures were analysed, with 250 ERC in patients with cirrhosis and 413 ERC in patients without cirrhosis. Data were analysed retrospectively from a prospectively acquired database using repeated measures logistic regression. RESULTS: Overall, 40 procedure-related complications were documented in 663 ERC interventions (6%). The rate of complications was similar between patients with and without cirrhosis (4.4% vs. 7.0%). First-time ERC was associated with a higher risk of complications (17.5% vs. 4.9%). Biliary sphincterotomy, stent placement and female sex, but not presence of liver cirrhosis, were identified as risk factors for overall complications in multivariate analysis. Patients without cirrhosis showed a significant decline of ALP and bilirubin levels after the first two interventions. In contrast, in patients with cirrhosis, ALP and bilirubin levels did not significantly decline after ERC. CONCLUSIONS: In patients with PSC, cirrhosis was not a risk factor for post-ERC complications. Therefore, cirrhosis should not preclude endoscopic intervention in patients with clear clinical indication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0202686

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flow chart of all patients included in the analysis. Out of a total of 383 patients with PSC managed at our centre, 208 patients received at least one ERC between 2009–2017. In 70 patients with 250 procedures, cirrhosis was detected. Another 138 patients with 413 ERC procedures had not progressed to cirrhosis.
Fig 1 Flow chart of all patients included in the analysis. Out of a total of 383 patients with PSC managed at our centre, 208 patients received at least one ERC between 2009–2017. In 70 patients with 250 procedures, cirrhosis was detected. Another 138 patients with 413 ERC procedures had not progressed to cirrhosis.CC BY · PubMed Central
Fig 2 Serum ALP and bilirubin levels before and after endoscopic intervention. Mean alkaline phosphatase (ALP) and bilirubin serum levels of patients without cirrhosis (A, B) and with cirrhosis (C, D) before and up to three months after therapeutic ERC. ERC = endoscopic retrograde cholangiography. *** P < 0.0001; ** p < 0.001; n.s. = not significant.
Fig 2 Serum ALP and bilirubin levels before and after endoscopic intervention. Mean alkaline phosphatase (ALP) and bilirubin serum levels of patients without cirrhosis (A, B) and with cirrhosis (C, D) before and up to three months after therapeutic ERC. ERC = endoscopic retrograde cholangiography. *** P < 0.0001; ** p < 0.001; n.s. = not significant.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 17

Metadata

Authors
Peiseler, M., Reiners, D., Pinnschmidt, H. O., Sebode, M., Jung, F., Hartl, J., Zenouzi, R., Ehlken, H., Groth, S., Schachschal, G., Rösch, T., Weiler-Normann, C., Lohse, A. W., & Schramm, C.
Affiliations
University Medical Center Hamburg-Eppendorf (DE)
Corresponding author
  • Peiseler, Moritz
  • Schramm, Christoph
Venue
PLOS ONE
Published
2018-08-20
Volume
13
Issue
8
Pages
e0202686
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2888098873
Cited by
17
References
36
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 1
FWCI
0.63
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (SFB 841, KFO306, SFB841, KFO306, SE 2665/1-1)
  • Helmut and Hannelore Greve Foundation
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary sclerosing cholangitis, liver cirrhosis, endoscopic retrograde cholangiography, biliary interventions, procedural complications, risk factors, endoscopic sphincterotomy, biliary stenting, obstructive cholestasis
MeSH terms
Sphincterotomy, Adult, Aged, Alkaline Phosphatase, Bilirubin, Cholangiopancreatography, Endoscopic Retrograde, Cholestasis, Female, Humans, Liver Cirrhosis, Male, Middle Aged, Postoperative Complications, Retrospective Studies, Risk Factors, Severity of Illness Index, Sex Factors, Cholangitis, Sclerosing, Stents, Logistic Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis. https://app.cochat.ai/papers/10.1371/journal.pone.0202686
The paper
Peiseler, M., Reiners, D., Pinnschmidt, H. O., Sebode, M., Jung, F., Hartl, J., Zenouzi, R., Ehlken, H., Groth, S., Schachschal, G., Rösch, T., Weiler-Normann, C., Lohse, A. W., & Schramm, C. (2018). Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0202686

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.